| Vasopressin and terlipressin: pharmacology and its clinical relevance. | |
| | |
MedLine Citation:
|
PMID: 15488059 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Vasopressin and its analogue, terlipressin, are potent vasopressors that may be useful therapeutic agents in the treatment of cardiac arrest, septic and catecholamine-resistant shock and oesophageal variceal haemorrhage. The aim of this article is to review the physiology and pharmacology of vasopressin and summarise its efficacy and safety in clinical trials and its subsequent therapeutic use. Recent studies indicate that the use of vasopressin during cardiopulmonary resuscitation may improve the survival of patients with asystolic cardiac arrest. Vasopressin deficiency can contribute to refractory shock states associated with sepsis, cardiogenic shock and cardiac arrest. Low doses of vasopressin and terlipressin can restore vasomotor tone in conditions that are resistant to catecholamines, with preservation of renal blood flow and urine output. They are also useful in reducing bleeding and mortality associated with oesophageal variceal haemorrhage. The long-term outcome of the use of these drugs is not known. |
| | |
Authors:
|
P C A Kam; S Williams; F F Y Yoong |
Related Documents
:
|
7039859 - Does ld100 e coli shock cause myocardial failure? 16484889 - Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmo... 6375989 - Renin and the complications of acute myocardial infarction. 506939 - Hypovolemia and hypotension complicating management of acute cardiogenic pulmonary edema. 20543669 - Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary interve... 16327039 - Four days of percutaneous cardiopulmonary support and sixteen days of percutaneous left... 18084319 - Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of... 7994079 - Elastic extracellular matrix of the embryonic chick heart: an immunohistological study ... 1422999 - Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Anaesthesia Volume: 59 ISSN: 0003-2409 ISO Abbreviation: Anaesthesia Publication Date: 2004 Oct |
Date Detail:
|
Created Date: 2004-10-18 Completed Date: 2004-12-30 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 0370524 Medline TA: Anaesthesia Country: England |
Other Details:
|
Languages: eng Pagination: 993-1001 Citation Subset: AIM; IM |
Affiliation:
|
Department of Anaesthesia, University of New South Wales, St George Hospital, Kogarah, New South Wales 2217, Australia. p.kam@unsw.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Esophageal and Gastric Varices / drug therapy Heart Arrest / drug therapy Humans Lypressin / analogs & derivatives*, pharmacology* Shock / drug therapy Vasoconstrictor Agents / pharmacology* Vasopressins / pharmacology*, physiology |
| Chemical | |
Reg. No./Substance:
|
0/Vasoconstrictor Agents; 11000-17-2/Vasopressins; 14636-12-5/terlipressin; 50-57-7/Lypressin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Extending low-dose epidural analgesia for emergency Caesarean section using ropivacaine 0.75%.
Next Document: Bibliometric analysis of original molecular biology research in anaesthesia.